INTECH Investment Management’s Haemonetics HAE Stock Holding History

INTECH Investment Management’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.4M	Sell	18,703 -14,223	-43%	-$914K	0.01%	866
2026 Q1	$1.86M	Buy	32,926 +14,337	+77%	+$934K	0.02%	737
2025 Q4	$1.49M	Sell	18,589 -8,900	-32%	-$598K	0.01%	898
2025 Q3	$1.34M	Sell	27,489 -7,463	-21%	-$462K	0.01%	1018
2025 Q2	$2.61M	Sell	34,952 -10,925	-24%	-$723K	0.02%	598
2025 Q1	$2.92M	Sell	45,877 -461	-1%	-$31.4K	0.03%	539
2024 Q4	$3.62M	Buy	46,338 +24,009	+108%	+$1.93M	0.04%	433
2024 Q3	$1.79M	Buy	22,329 +8,626	+63%	+$697K	0.02%	524
2024 Q2	$1.13M	Buy	+13,703	New	+$1.21M	0.01%	597

Other funds holding HAE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

INTECH Investment Management's HAE Position: Q2 2026 in Review

INTECH Investment Management reduced its Haemonetics (HAE) stake by 43% in Q2 2026, selling an estimated $914K and leaving 18,703 shares worth $1.4M. The position accounts for 0.01% of the portfolio, ranked #866.

INTECH Investment Management first reported a position in HAE in Q2 2024 and has held it in 9 quarters since. The position peaked at $3.62M in Q4 2024. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

INTECH Investment Management held 18,703 shares of Haemonetics worth $1.4M as of Q2 2026.
INTECH Investment Management sold 14,223 Haemonetics shares in Q2 2026, an estimated $914K.
Haemonetics made up 0.01% of INTECH Investment Management's portfolio in Q2 2026, its #866 holding.
INTECH Investment Management first reported a position in Haemonetics in Q2 2024 and has held it in 9 quarters since.
INTECH Investment Management's Haemonetics position peaked at $3.62M in Q4 2024.
329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.